References
- Park HK, Park CB. 2009. A trend analysis of herbal crop industry. Abstract presented at Annual Meeting of the Korean Society of Breeding Science. Daejeon, Korea. p 36.
- Heo J. 2005. Donguibogam. Bubin Publishers, Seoul, Korea. p 1323.
- Choi TH, Cho NS. 1996. New Korean traditional papermaking from paper mulberry (I). J Korea TAPPI 28: 49-59.
- Ikuta J, Hano Y, Nomura T, Kawakami Y, Sato T. 1986. Components of Broussonetia kazinoki SIEB. I. Structures of two new isoprenylated flavans and five new isoprenylated 1, 3-diphenylpropane derivatives. Chem Pharm Bull 34: 1968-1979. https://doi.org/10.1248/cpb.34.1968
- Ko HH, Yen MH, Wu RR, Won SJ, Lin CN. 1999. Cytotoxic isoprenylated flavans of Broussonetia kazinoki. J Nat Prod 62: 164-166. https://doi.org/10.1021/np980281c
- Zhang PC, Wang S, Wu Y, Chen RY, Yu DQ. 2001. Five new diprenylated flavonols from the leaves of Broussonetia kazinoki. J Nat Prod 64: 1206-1209. https://doi.org/10.1021/np010283o
- Tsukamoto D, Shibano M, Okamoto R, Kusano G. 2001. Studies on the constituents of Broussonetia species VIII. Four new pyrrolidine alkaloids, broussonetines R, S, T, and V and a new pyrroline alkaloid, broussonetine U, from Broussonetia kazinoki Sieb. Chem Pharm Bull 49: 492-496. https://doi.org/10.1248/cpb.49.492
- Lee JK, Ha H, Lee HY, Park SJ, Jeong SI, Choi YJ, Shin HK. 2010. Inhibitory effects of heartwood extracts of Broussonetia kazinoki Sieb on the development of atopic dermatitis in NC/Nga mice. Biosci Biotechnol Biochem 74: 1802-1806. https://doi.org/10.1271/bbb.100138
- Park SA, Ha JH, Park SN. 2013. Antioxidative activity and component analysis of Borussonetia kazinoki SIEB extracts. Appl Chem Eng 44: 177-183.
- Lee HJ, Park JH, Jang DI, Ryu JH. 1997. Antioxidant components from Broussonetia kazinoki. Yakhak Hoechi 41: 439-443.
- Ryu JH, Ahn H, Lee HJ. 2003. Inhibition of nitric oxide production on LPS-activated macrophages by kazinol B from Broussonetia kazinoki. Fitoterapia 74: 350-354. https://doi.org/10.1016/S0367-326X(03)00062-5
- Jang DI, Lee BG, Jeon CO, Jo NS, Park JH, Cho SY. 1997. Melanogenesis inhibitor form paper mulberry. Cosmetics & Toiletries 112: 59-62.
- Ahn JH, Liu Q, Lee C, Ahn MJ, Yoo HS, Hwang BY, Lee MK. 2012. A new pancreatic lipase inhibitor from Broussonetia kanzinoki. Bioorg Med Chem Lett 22: 2760-2763. https://doi.org/10.1016/j.bmcl.2012.02.088
- Lee H, Li H, Jeong JH, Noh M, Ryu JH. 2016. Kazinol B from Broussonetia kazinoki improves insulin sensitivity via Akt and AMPK activation in 3T3-L1 adipocytes. Fitoterapia 112: 90-96. https://doi.org/10.1016/j.fitote.2016.05.006
-
Bae UJ, Jang HY, Lim JM, Hua L, Ryu JH, Park BH. 2015. Polyphenols isolated from Broussonetia kazinoki prevent cytokine-induced
${\beta}$ -cell damage and the development of type 1 diabetes. Exp Mol Med 47: e160. https://doi.org/10.1038/emm.2015.16 - Jung YC, Han S, Hua L, Ahn YH, Cho H, Lee CJ, Lee H, Cho YY, Ryu JH, Jeon R, Kim WY. 2016. Kazinol-E is a specific inhibitor of ERK that suppresses the enrichment of a breast cancer stem-like cell population. Biochem Biophys Res Commun 470: 294-299. https://doi.org/10.1016/j.bbrc.2016.01.066
- Griffioen AW, Molema G. 2010. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52: 237-268.
- Kim JH, Kim JK, Ahn EK, Ko HJ, Cho YR, Lee CH, Kim YK, Bae GU, Oh JS, Seo DW. 2015. Marmesin is a novel angiogenesis inhibitor: Regulatory effect and molecular mechanism on endothelial cell fate and angiogenesis. Cancer Lett 369: 323-330. https://doi.org/10.1016/j.canlet.2015.09.021
- KFDA. 2004. Analytical method guideline about validation of drugs and etc. Korea Food & Drug Administration, Seoul, Korea. p 1-18.
Cited by
- 닥나무 인피섬유와 한지의 원산지 판별모델 개발을 위한 NIR 및 MIR 스펙트럼 데이터의 PLS-DA 적용 vol.32, pp.1, 2016, https://doi.org/10.5806/ast.2019.32.1.7
- Analytical method validation of ellagic acid as an antioxidative marker compound of the Rubus occidentalis extract vol.28, pp.5, 2016, https://doi.org/10.11002/kjfp.2021.28.5.663